Response to 'Cesarean section or non-breastfeeding for prevention of MTCT - Beware of sending the wrong message'
- PMID: 33382164
- DOI: 10.1111/jvh.13464
Response to 'Cesarean section or non-breastfeeding for prevention of MTCT - Beware of sending the wrong message'
Abstract
We are glad to respond to the concerns of Drs. Levy and Terrault about our articles on the mother-to-child transmission (MTCT) of hepatitis B virus (HBV) in HBeAg-positive mothers. We agree with Drs. Levy and Terrault that antiviral therapy of HBV during pregnancy could effectively decrease the MTCT, and this strategy has been recommended by WHO for pregnant women with a high viral load. However, the long-term influences of the abrupt cessation of antiretroviral drugs in mothers and prenatal exposure to antiviral drugs in newborns are not completely understood and are still under investigation. And not all pregnant mothers would accept this regiment due to the medication availability and individual willingness. It makes sense to study the influential factors on MTCT among mothers with high-risk transmission but not taking antiviral drugs. Despite the relatively large number of subjects included in our cohort (N = 857), post hoc power computation shows that the test efficacy is far from adequate to detect the association between delivery mode or feeding type and HBV MTCT. Therefore, we summarized the relevant studies to reach a relatively reasonable conclusion in HBsAg- and HBeAg-positive pregnant mothers not taking antiviral drugs. We provide an alternative option for HBsAg- and HBeAg-positive pregnant mothers who cannot access or defer to antiviral therapy during pregnancy to reduce the risk of HBV transmission to their offspring.
Keywords: delivery mode; feeding mode; hepatitis B virus; mother-to-infant transmission.
© 2021 John Wiley & Sons Ltd.
Comment on
-
The role of caesarean section and nonbreastfeeding in preventing mother-to-child transmission of hepatitis B virus in HBsAg-and HBeAg-positive mothers: results from a prospective cohort study and a meta-analysis.J Viral Hepat. 2020 Oct;27(10):1032-1043. doi: 10.1111/jvh.13314. Epub 2020 May 22. J Viral Hepat. 2020. PMID: 32362050
-
Caesarean section or non-breastfeeding for prevention of MTCT-beware of sending the wrong message.J Viral Hepat. 2021 Mar;28(3):575-576. doi: 10.1111/jvh.13455. Epub 2021 Jan 19. J Viral Hepat. 2021. PMID: 33305401 No abstract available.
References
REFERENCES
-
- Levy MT, Terrault NA. Caesarean section or non-breastfeeding for prevention of MTCT - beware of sending the wrong message. J Viral Hepat. 2020. https://doi.org/10.1111/jvh.13455. [Epub ahead of print.]
-
- Pan YC, Jia ZF, Wang YQ, et al. The role of caesarean section and nonbreastfeeding in preventing mother-to-child transmission of hepatitis B virus in HBsAg-and HBeAg-positive mothers: results from a prospective cohort study and a meta-analysis. J Viral Hepat. 2020;27(10):1032-1043.
-
- World Health Organization. Prevention of Mother-to-child Transmission of Hepatitis B Virus: Guidelines on Antiviral Prophylaxis in Pregnancy: Web Annex B: Systematic Review of the Performance of Hepatitis B e Antigen Test, as an Alternative to HBV DNA, to Assess Eligibility for Initiating Antiviral Therapy during Pregnancy. Geneva: World Health Organization; 2020.
-
- Xiao LX, Chen YR, Huang P, et al. The safety of antiviral therapy and drug withdrawal for the prevention of mother-to-child transmission of HBV during pregnancy. J Med Virol. 2020;92(12):3381-3389.
-
- Polaris Observatory Collaborators. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3(6):383-403.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
